[
    {
        "trialName": "Diabetes RElated to Acute Pancreatitis and Its Mechanisms (DREAM) An Observational Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)",
        "nctNumber": "NCT05197920",
        "statusVerifiedDate": "2024-05",
        "overallStatus": "RECRUITING",
        "startDate": "2022-01-14",
        "primaryCompletionDate": "2025-04-30",
        "completionDate": "2025-04-30",
        "studyFirstSubmitDate": "2021-12-11",
        "lastUpdateSubmitDate": "2024-05-02",
        "startDateType": "ACTUAL",
        "durationDays": 1202,
        "daysUntilEnd": 264
    },
    {
        "trialName": "TrialNet Pathway to Prevention of T1D",
        "nctNumber": "NCT00097292",
        "statusVerifiedDate": "2023-12",
        "overallStatus": "RECRUITING",
        "startDate": "2004-02",
        "primaryCompletionDate": "2025-07",
        "completionDate": "2025-07",
        "studyFirstSubmitDate": "2004-11-19",
        "lastUpdateSubmitDate": "2023-12-20",
        "startDateType": "",
        "durationDays": 7821,
        "daysUntilEnd": 326
    },
    {
        "trialName": "A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subtype-Selective JAK Inhibitors for Preservation of Pancreatic \u03b2 Cell Function in Newly Diagnosed Type 1 Diabetes Mellitus",
        "nctNumber": "NCT05743244",
        "statusVerifiedDate": "2023-10",
        "overallStatus": "RECRUITING",
        "startDate": "2023-10-19",
        "primaryCompletionDate": "2026-06-30",
        "completionDate": "2027-06-30",
        "studyFirstSubmitDate": "2023-02-03",
        "lastUpdateSubmitDate": "2024-07-09",
        "startDateType": "ACTUAL",
        "durationDays": 1350,
        "daysUntilEnd": 1055
    },
    {
        "trialName": "Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes",
        "nctNumber": "NCT03929601",
        "statusVerifiedDate": "2023-12",
        "overallStatus": "RECRUITING",
        "startDate": "2023-10-30",
        "primaryCompletionDate": "2027-10",
        "completionDate": "2029-10",
        "studyFirstSubmitDate": "2018-05-16",
        "lastUpdateSubmitDate": "2024-07-16",
        "startDateType": "ACTUAL",
        "durationDays": 2163,
        "daysUntilEnd": 1879
    },
    {
        "trialName": "Single Arm, Open-label Study to Assess the Safety and Pharmacokinetics of a 14-day Regimen of Teplizumab in Pediatric Stage 2 Type 1 Diabetes (Participants <8 Years of Age With at Least Two Autoantibodies and Dysglycemia)",
        "nctNumber": "NCT05757713",
        "statusVerifiedDate": "2024-04",
        "overallStatus": "RECRUITING",
        "startDate": "2023-07-25",
        "primaryCompletionDate": "2026-10",
        "completionDate": "2026-10",
        "studyFirstSubmitDate": "2023-02-13",
        "lastUpdateSubmitDate": "2024-04-12",
        "startDateType": "ACTUAL",
        "durationDays": 1164,
        "daysUntilEnd": 783
    },
    {
        "trialName": "Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home",
        "nctNumber": "NCT02748018",
        "statusVerifiedDate": "2024-01",
        "overallStatus": "RECRUITING",
        "startDate": "2017-05-25",
        "primaryCompletionDate": "2024-03",
        "completionDate": "2024-09",
        "studyFirstSubmitDate": "2016-04-19",
        "lastUpdateSubmitDate": "2024-01-18",
        "startDateType": "ACTUAL",
        "durationDays": 2656,
        "daysUntilEnd": 23
    },
    {
        "trialName": "TArgeting Type 1 Diabetes Using POLyamines (TADPOL): A Randomized, Double-Masked, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Difluoromethylornithine (DFMO) to Preserve Insulin Production in Type 1 Diabetes",
        "nctNumber": "NCT05594563",
        "statusVerifiedDate": "2024-05",
        "overallStatus": "RECRUITING",
        "startDate": "2023-03-14",
        "primaryCompletionDate": "2027-12",
        "completionDate": "2027-12",
        "studyFirstSubmitDate": "2022-10-12",
        "lastUpdateSubmitDate": "2024-05-30",
        "startDateType": "ACTUAL",
        "durationDays": 1723,
        "daysUntilEnd": 1209
    },
    {
        "trialName": "Low Dose Antithymocyte Globulin (ATG) to Delay or Prevent Progression to Stage 3 T1D",
        "nctNumber": "NCT04291703",
        "statusVerifiedDate": "2024-05",
        "overallStatus": "RECRUITING",
        "startDate": "2023-11-01",
        "primaryCompletionDate": "2028-12-31",
        "completionDate": "2029-12-31",
        "studyFirstSubmitDate": "2020-02-26",
        "lastUpdateSubmitDate": "2024-05-24",
        "startDateType": "ACTUAL",
        "durationDays": 2252,
        "daysUntilEnd": 1970
    },
    {
        "trialName": "A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita\u00ae System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control",
        "nctNumber": "NCT04419779",
        "statusVerifiedDate": "2024-05",
        "overallStatus": "RECRUITING",
        "startDate": "2021-03-08",
        "primaryCompletionDate": "2025-06",
        "completionDate": "2026-01",
        "studyFirstSubmitDate": "2020-06-03",
        "lastUpdateSubmitDate": "2024-07-15",
        "startDateType": "ACTUAL",
        "durationDays": 1760,
        "daysUntilEnd": 510
    },
    {
        "trialName": "The Gut Microbiome in Lean and Overweight Youth With Type 1 Diabetes and Novel Mechanism of Action of Metformin",
        "nctNumber": "NCT05414409",
        "statusVerifiedDate": "2024-05",
        "overallStatus": "RECRUITING",
        "startDate": "2022-09-28",
        "primaryCompletionDate": "2026-08-01",
        "completionDate": "2026-08-01",
        "studyFirstSubmitDate": "2022-05-31",
        "lastUpdateSubmitDate": "2024-05-29",
        "startDateType": "ACTUAL",
        "durationDays": 1403,
        "daysUntilEnd": 722
    },
    {
        "trialName": "Type 1 Diabetes Extension Study",
        "nctNumber": "NCT02734277",
        "statusVerifiedDate": "2024-04",
        "overallStatus": "RECRUITING",
        "startDate": "2016-08-18",
        "primaryCompletionDate": "2025-03",
        "completionDate": "2025-03",
        "studyFirstSubmitDate": "2016-04-06",
        "lastUpdateSubmitDate": "2024-04-23",
        "startDateType": "ACTUAL",
        "durationDays": 3117,
        "daysUntilEnd": 204
    },
    {
        "trialName": "Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON) - An Observational Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)",
        "nctNumber": "NCT06401577",
        "statusVerifiedDate": "2024-07",
        "overallStatus": "NOT_YET_RECRUITING",
        "startDate": "2024-09-01",
        "primaryCompletionDate": "2026-12-31",
        "completionDate": "2027-03-31",
        "studyFirstSubmitDate": "2024-05-02",
        "lastUpdateSubmitDate": "2024-07-30",
        "startDateType": "ESTIMATED",
        "durationDays": 941,
        "daysUntilEnd": 964
    }
]